JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YAMAMURA, H. I.
Right arrow Articles by HORITA, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YAMAMURA, H. I.
Right arrow Articles by HORITA, A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 164, Issue 1, 82-89, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


EFFECT OF PROPRANOLOL ON THE BLOCKADE OF ALPHA ADRENERGIC RECEPTORS

HENRY I. YAMAMURA 1 and AKIRA HORITA 1

1 Department of Pharmacology, School of Medicine, University of Washington, Seattle, Washington

Previous studies from this laboratory have demonstrated the antagonism of various alpha blockers by the beta blocking agent, dichloroisoproterenol. In the present studies, the alpha responses of agents possessing both alpha and beta adrenergic properties (epinephrine and norepinephrine) were antagonized by phenoxybenzamine and exhibited partial recovery after subsequent administration of propranolol. However, the alpha responses of agents possessing only an alpha stimulatory property (methoxamine and oxymetazoline) were not restored upon subsequent administration of propranolol. It was also shown that, even after the antagonism of phenoxybenzamine by propranolol, the phenoxybenzamine-induced blockade reappeared after the effects of propranolol had dissipated. These data therefore demonstrate that only the agonist possessing both alpha and beta activities can undergo the reversal and recovery. It is postulated that this antagonism does not involve a displacement mechanism of phenoxybenzamine by propranolol but is associated with the unmasking of residual alpha receptor sites which were not blocked by the original dose of phenoxybenzamine.

Submitted on September 29, 1967
Accepted on June 21, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.